Global Alliance for Genomics and Health

Global Alliance for Genomics and Health is an international organization that aims to accelerate progress in genomics and precision medicine through collaboration and data sharing among its members, which include National Institutes of Health, Wellcome Trust, Bill and Melinda Gates Foundation, and World Health Organization. The alliance was founded in 2013 by David Altshuler, Eric Lander, and Francis Collins, with the goal of creating a global framework for sharing genomic data and promoting genomic medicine. This initiative has been supported by European Bioinformatics Institute, National Cancer Institute, and University of California, San Francisco, among others. The alliance has also collaborated with International Cancer Genome Consortium, The Cancer Genome Atlas, and Genomic Data Commons to advance cancer genomics research.

● Introduction

The Global Alliance for Genomics and Health is a non-profit organization that brings together research institutions, hospitals, pharmaceutical companies, and patient advocacy groups from around the world to share knowledge, resources, and expertise in genomics and healthcare. The alliance is committed to promoting data sharing, standardization, and collaboration among its members, with the ultimate goal of improving human health and wellbeing. This effort has been endorsed by American Medical Association, National Academy of Medicine, and European Society of Human Genetics, among others. The alliance has also partnered with Google, Microsoft, and Amazon Web Services to develop cloud-based platforms for genomic data analysis and storage, such as Google Genomics and Microsoft Azure.

● History

The Global Alliance for Genomics and Health was launched in 2013 at a meeting hosted by Harvard University and Broad Institute, with the participation of National Human Genome Research Institute, European Molecular Biology Laboratory, and Sanger Institute. The alliance was established in response to the growing need for a global framework for sharing genomic data and promoting genomic medicine, as highlighted by Human Genome Project, 1000 Genomes Project, and Exome Aggregation Consortium. Since its inception, the alliance has grown to include over 500 organizations from more than 70 countries, including Stanford University, University of Oxford, and Chinese Academy of Sciences. The alliance has also collaborated with World Economic Forum, National Academy of Sciences, and Institute of Medicine to promote global health and genomic research.

● Organization and Membership

The Global Alliance for Genomics and Health is governed by a board of directors that includes representatives from founder organizations, such as National Institutes of Health, Wellcome Trust, and Bill and Melinda Gates Foundation. The alliance has a secretariat that is responsible for coordinating the activities of the organization, with support from University of California, Los Angeles, Duke University, and University of Toronto. Membership in the alliance is open to any organization that shares the alliance's goals and values, including research institutions, hospitals, pharmaceutical companies, and patient advocacy groups, such as American Cancer Society, March of Dimes, and Cystic Fibrosis Foundation. The alliance has also established partnerships with European Commission, National Science Foundation, and Canadian Institutes of Health Research to promote international collaboration and knowledge sharing.

● Standards and Policies

The Global Alliance for Genomics and Health has developed a set of standards and policies for sharing genomic data, including the Genomic Data Sharing Policy and the Data Use and Sharing Agreement. These standards and policies are designed to ensure that genomic data is shared in a responsible and secure manner, with respect for patient privacy and informed consent, as outlined by Health Insurance Portability and Accountability Act and General Data Protection Regulation. The alliance has also established a Data Access Committee that reviews requests for access to genomic data and ensures that data is shared in accordance with the alliance's policies, with input from National Institute of Standards and Technology, European Data Protection Board, and International Organization for Standardization. The alliance has collaborated with National Center for Biotechnology Information, European Bioinformatics Institute, and Database of Genotypes and Phenotypes to develop data standards and metadata for genomic research.

● Projects and Initiatives

The Global Alliance for Genomics and Health has launched several projects and initiatives aimed at promoting genomic research and precision medicine, including the Genomic Data Commons and the Matchmaker Exchange. The alliance has also established a Clinical Genome Resource that provides clinical genomics data and interpretation to support genomic medicine, with contributions from ClinGen, Genomics England, and Australian Genomics Health Alliance. The alliance has collaborated with National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, and National Institute on Aging to advance neurogenomics and psychiatric genomics research. The alliance has also partnered with Food and Drug Administration, European Medicines Agency, and World Health Organization to promote regulatory harmonization and standardization in genomic medicine.

● Impact and Achievements

The Global Alliance for Genomics and Health has made significant progress in promoting genomic research and precision medicine since its inception, with support from National Science Foundation, European Research Council, and Canadian Institutes of Health Research. The alliance has facilitated the sharing of genomic data among its members, leading to new insights and discoveries in genomics and healthcare, as reported by Nature, Science, and New England Journal of Medicine. The alliance has also established a global framework for genomic data sharing and standardization, with the goal of improving human health and wellbeing, as endorsed by World Health Organization, United Nations, and European Union. The alliance has collaborated with American Heart Association, American Diabetes Association, and National Kidney Foundation to advance genomic research in cardiovascular disease, diabetes, and kidney disease. The alliance has also partnered with Google, Microsoft, and Amazon Web Services to develop cloud-based platforms for genomic data analysis and storage, such as Google Genomics and Microsoft Azure. Category:Genomics